See also this year's filing and all EDGAR filings for this company.
PDF Report 0001439725_2021_BIODESIX_INC.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.22391025641025641, 'aggregate_val': 121070000, 'exp_sum': 156000000, 'exp_to_value': {'IntangibleAssets': 28291000, 'AssetsNonCurrent': 34930000, 'AssetsCurrent': 86140000, 'PropertyPlantAndEquipment': 3178000, 'remainder_Assets': 3461000}} |
Graph
Absolute values for 0001439725, BIODESIX INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 28,291,000 |
| 1 | AssetsNonCurrent | 34,930,000 |
| 2 | AssetsCurrent | 86,140,000 |
| 3 | PropertyPlantAndEquipment | 3,178,000 |
| 4 | remainder_Assets | -31,469,000 |
| 5 | LongTermLiabilities | 47,779,000 |
| 6 | LiabilitiesCurrent | 32,125,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 34,857,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 10,818,000 |
| 16 | remainder_Expenses | 22,816,000 |
| 17 | remainder_Revenues | 45,557,000 |
| 18 | remainder_NetIncome | -8,416,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 121,070,000 |
| 1 | Liabilities | 79,904,000 |
| 2 | Expenses | 68,491,000 |
| 3 | Revenues | 45,557,000 |
| 4 | StockholdersEquity | 41,166,000 |
| 5 | NetIncome | -31,350,000 |
| 6 | ComprehensiveNetIncome | -31,350,000 |
| 7 | BaseVar | 181,925,560 |
| 8 | EconomicCapitalRatio | 0.277 |
Edgar->Model Mapping
Feature Distribution
Change over Time
